UBS Group AG - Vivoryon Therapeutics N.V. - Halle
Below you will find information from the register substantial holdings and gross short positions. The information has been provided by the organisation.
Date of transaction
11 mar 2024
Person obliged to notify
UBS Group AG
Issuing institution
Vivoryon Therapeutics N.V.
Place of residence
Halle
Distribution in numbers
| Type of share | Number of shares | Number of voting rights | Capital interest | Voting rights | Manner of disposal | Settlement |
|---|---|---|---|---|---|---|
| Type of shareGewoon aandeel | Number of shares383.196,00 | Number of voting rights383.196,00 | Capital interestPotentieel | Voting rightsPotentieel | Manner of disposalMiddellijk (UBS AG, UBS Switzerland AG) | SettlementFysieke levering |
| Type of shareGewoon aandeel | Number of shares215.972,00 | Number of voting rights215.972,00 | Capital interestReëel | Voting rightsReëel | Manner of disposalMiddellijk (UBS AG, UBS Asset Management (UK) Limited, UBS Europe SE, UBS Fund Management (Luxembourg) S.A., Credit Suisse (Schweiz) AG) | SettlementFysieke levering |
Distribution in percentages
| Type | Total holding | Directly real | Directly potential | Indirectly real | Indirectly potential |
|---|---|---|---|---|---|
| TypeKapitaalbelang | Total holding2,30 % | Directly real0,00 % | Directly potential0,00 % | Indirectly real0,83 % | Indirectly potential1,47 % |
| TypeStemrecht | Total holding2,30 % | Directly real0,00 % | Directly potential0,00 % | Indirectly real0,83 % | Indirectly potential1,47 % |
Date last update: 18 March 2026